改善患者的认知功能。鉴于接受该药治疗的患者体内S-100.docVIP

文章研究了醒脑静对阻塞性睡眠呼吸暂停综合征患者的影响，结果表明醒脑静可以改善患者的认知功能。鉴于接受该药治疗的患者体内S-100β蛋白相对低表达，作者推测，醒脑静的作用机制可能与下调S-100β蛋白有关。从选题和论述角度来看，这是一篇较好的学术论文，具有一定的学术价值。文末所附为该文的一些瑕疵，S-100β在不同组别间有差异，而NSE则变化不大，而二者均为“射液要成分为麝香、冰片、郁金、栀子分析法Influence of xingnaojing on S-100β and NSE in patients with obstructive sleep apnea-hypopnea syndrome Patients”中 patients 重复；“OSAS patients’serum levels of S-100β protein were higher than the levels of the control group” 语法错误。建议请专业人员修改。 参考文献 文献偏旧，建议查新。 文献格式不统一，建议严格按《实用临床医学》要求重新排版； 参考文献中部分笔误，如文献7中glial-derived?误写为glial—dcfivcd，Beneficialk。类似错误较多，建议认真核对，正确引用。OSAS与OSAHS混用。醒脑静对阻塞性睡眠呼吸暂停综合征OSAS患者血清NSE蛋白水平的影响阻塞性睡眠呼吸暂停综合征OSAS组和醒脑静治疗组，OSAS组未用药物治疗，治疗组进行醒脑静治疗。选取同期体检的健康人员30例，作为正常对照组。以ELISA法检测各组血清S-100β和NSE蛋白水平阻塞性睡眠呼吸暂停综合征S-100β蛋白水平NSE蛋白水平S-100β蛋白水平NSE蛋白水平阻塞性睡眠呼吸暂停综合征OSAS患者血清S-100β蛋白Influence of xingnaojing on S-100β and NSE in patients with obstructive sleep apnea-hypopnea syndrome Patients [Abatract]Objective:To observe Influence of xingnaojing on S-100β and NSE in patients with obstructive sleep apnea-hypopnea syndrome Patients. protein．Methods:60 male patients with OSAHS．were randomly divided into treatment group which was treated with xingnaojing and OSAS group, who were evaluated by full—night polysomnog-raphy,and 30 male healthy persons as control subjects were studied． S-100β and NSE were detected after treatment by ELISA. Results :OSAS patients’serum levels of S-100β protein were higher than the levels of the control group．But comparatively,the levels of the OSAHS group and the control group of the NSE were similar，without significant differences．Compared with OSAS group，the XNJ group patients’serum levels of S-100β protein were lower,But c the NSE were similar，without significant differences．Conclusion:xingnaojing can treat OSAS patients by reducing the serum leves of S-100β,significantly improve clinical efficacy. 阻塞性睡眠呼吸暂停综合征(obstructive sleep apnea-hypopnea syndrome，OSAS)是一种慢性睡眠呼吸障碍，可累计多个系统，认知功能损害是神经系统受累的一种表现，受到人们的广泛关注。对脑组织的生化标志物进行检测，对OSAS患者的脑损害可以作出早期的评估。研究已显示脑脊液和血浆中S-